Month: June 2020

Top federal health officials told lawmakers Tuesday the U.S. needs a more unified national response and funding for public health funding if the country faces another pandemic.  The U.S. is now reporting nearly 40,000 new coronavirus cases every day — almost double from about 22,800 in mid-May — driven largely by outbreaks in a number of states
0 Comments
With pinging mobiles and thumping music taking over every element of our day, silence is a rarity in the modern world. But, could switching off from these sounds help us improve our physical and emotional health? Can you hear that? It’s the sound of constant noise. We’re bombarded 24/7 by sounds of some sort –
0 Comments
A country’s response to a monumental crisis is reliant upon political leadership that presents a united front. This was not the case when COVID-19 first struck the United States. Democrats and Republicans failed to see eye to eye on appropriate mitigation strategies at that point in time.  The public takes cues from elected Congressmen about behavioral changes they
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Colchicine, an anti-inflammatory drug used to treat gout and rheumatic disease, may be a promising treatment for COVID-19, a randomized, open-label trial suggests. In the Greek Study in the Effects of Colchicine in COVID-19 Complications Prevention (GRECCO-19), investigators randomly assigned 105
0 Comments
Reviewed by Emily Henderson, B.Sc.Jun 30 2020 A Miami entrepreneur who led a rural hospital empire was charged in an indictment unsealed Monday in what federal prosecutors called a $1.4 billion fraudulent lab-billing scheme. In the indictment, prosecutors said Jorge A. Perez, 60, and nine others exploited federal regulations that allow some rural hospitals to
0 Comments
FDA Approves Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) for HER2-Positive Breast Cancer Print this page South San Francisco, CA — June 29, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Phesgo, a fixed-dose combination (FDC) of Perjeta® (pertuzumab)
0 Comments
In patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), nearly 30% responded to treatment with the selective inhibitor of nuclear export selinexor (Xpovio), a single-arm phase IIb trial showed. In SADAL, 28% of the 127 patients with two to five lines of prior therapy responded to the twice-weekly 60-mg dose of the drug
0 Comments
Our group of college friends planned to attend alumni weekend in June. But cancer and COVID changed our plans. Through a series of messages, and phone calls, we heard the news: it is cancer. The cancer diagnosis and treatment planning all happened during COVID. We still wanted to celebrate our friendship, so we planned our
0 Comments
Anne Schuchat, director of the Centers for Disease Control (CDC), speaks during a U.S. Senate Committee on Health, Education, Labor, and Pensions hearing at the U.S. Capitol in Washington, D.C., on Tuesday, March 3, 2020. Stefani Reynolds | Bloomberg via Getty Images The coronavirus is spreading too rapidly and too broadly for the U.S. to
0 Comments
Several recent studies have documented the rising cases of mental health problems during the current global health crisis, indicating that these psychological problems could be the next pandemic of sorts.  After our physical health was put at risk, the economy suffered massive losses. Following that, a third wave of catastrophic occurrences seem to be next.
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A new review outlines a three-stage classification of the impact of COVID-19 on the central nervous system and recommends hospitalized patients with the virus all undergo MRI to flag potential neurologic damage and inform postdischarge monitoring. In stage 1, viral damage
0 Comments
Print this page NORTH CHICAGO, Ill., June 26, 2020 /PRNewswire/ – Allergan, an AbbVie Company (NYSE: ABBV), and Molecular Partners (SIX: MOLN), a clinical-stage biotechnology company developing a new class of custom-built protein therapeutics known as DARPin® therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter to the Biologics License
0 Comments
casimersen Treatment for Duchenne Muscular Dystrophy Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Casimersen (SRP-4045) for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45 Print this page CAMBRIDGE, Mass., June 26, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today
0 Comments
Print this page CAMBRIDGE, Mass. and TARRYTOWN, N.Y., June 19, 2020 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a 300 mg single-dose pre-filled pen for Dupixent® (dupilumab). The pre-filled pen is approved for all Dupixent indications in patients aged 12 years and older, which includes use in certain patients with atopic dermatitis, asthma and chronic rhinosinusitis with
0 Comments
In a three-part “Clinical Challenges” series, MedPage Today addressed several aspects of ovarian cancer: the use of so-called PARP inhibitors; repeat cytoreductive surgery following recurrence; and management of platinum-resistant disease. Test your knowledge on one aspect of each of these topics with this three-question quiz. Correct answers and explanations will appear after completing the quiz.
0 Comments
With government support, three coronavirus vaccines are expected to be studied in large-scale clinical trials in the next three months. “The best we’ve ever done is measles, which is 97 to 98 percent effective,” said Fauci, the director of the National Institute of Allergy and Infectious Diseases. “That would be wonderful if we get there.
0 Comments
COVID-19 has already affected 10.1 million people worldwide. Health experts said numbers will continue to grow and the disease may even spread faster as many countries, including the U.S., have been slowly reopening and lifting lockdowns.  There is currently no vaccine available to stop the coronavirus from infecting people. Treatments designed specifically for the disease
0 Comments